4.4 Article

Amyloid β protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease

Journal

NEUROSCIENCE LETTERS
Volume 304, Issue 1-2, Pages 102-106

Publisher

ELSEVIER SCI IRELAND LTD
DOI: 10.1016/S0304-3940(01)01754-2

Keywords

Alzheimer disease; amyloid beta protein; alpha 1-antichymotrypsin; apolipoprotein E; enzyme linked immunosorbent assay

Categories

Ask authors/readers for more resources

We quantitated amyloid beta proteins 1-40 (A beta 40) and 1-42 (A beta 42), and alpha1-antichymotrypsin (ACT) in matched cerebrospinal fluid (CSF) and plasma of 50 patients with probable Alzheimer disease, and analyzed the relationships with age, sex, Mini-Mental State Examination (MMSE), and apolipoprotein E phenotype. There was no relation between CSF A beta 40 and A beta 42 levels with those of plasma. CSF and plasma A beta 40 and A beta 42 levels showed no association with age, sex, and MMSE score. There was a significant correlation between CSF ACT and plasma ACT levels. The data suggest that plasma ACT crosses the blood-brain barrier. However, a lack of correlation between CSF A beta 40 and A beta 42 levels with those of plasma suggests that A beta in CSF and plasma originates from different sources. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available